Demichelis, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.169
EU - Europa 1.639
AS - Asia 513
OC - Oceania 50
AF - Africa 26
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.420
Nazione #
US - Stati Uniti d'America 3.072
IT - Italia 860
CN - Cina 180
DE - Germania 115
GB - Regno Unito 111
CA - Canada 90
CZ - Repubblica Ceca 79
RU - Federazione Russa 68
VN - Vietnam 62
JP - Giappone 60
IN - India 58
NL - Olanda 56
FR - Francia 52
SE - Svezia 52
HK - Hong Kong 48
ES - Italia 46
AU - Australia 41
CH - Svizzera 38
UA - Ucraina 25
BE - Belgio 22
ZA - Sudafrica 22
LU - Lussemburgo 20
DK - Danimarca 15
FI - Finlandia 13
IE - Irlanda 11
SG - Singapore 11
CL - Cile 10
HU - Ungheria 10
PK - Pakistan 10
ID - Indonesia 9
MY - Malesia 9
NZ - Nuova Zelanda 9
PH - Filippine 9
PT - Portogallo 9
TR - Turchia 9
TW - Taiwan 9
BR - Brasile 8
KR - Corea 8
IR - Iran 7
NO - Norvegia 7
GR - Grecia 6
AT - Austria 4
MX - Messico 4
PL - Polonia 4
TH - Thailandia 4
IQ - Iraq 3
JO - Giordania 3
RO - Romania 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CY - Cipro 2
HR - Croazia 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
PR - Porto Rico 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BT - Bhutan 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
HN - Honduras 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
PE - Perù 1
VE - Venezuela 1
YE - Yemen 1
Totale 5.420
Città #
Fairfield 447
Ashburn 249
Woodbridge 208
Santa Cruz 200
Seattle 199
Houston 190
Trento 181
Cambridge 146
Civitanova Marche 117
Wilmington 112
Buffalo 100
Ann Arbor 90
Como 80
Chicago 53
Milan 46
Dong Ket 44
Beijing 42
San Diego 41
Edmonton 40
Stockholm 40
New York 39
Los Angeles 35
Dallas 31
Brunico 23
Shanghai 23
Tolentino 23
Boardman 22
Fleming Island 22
Las Vegas 22
Central 20
Rome 20
Tokyo 20
Des Moines 19
Hesperange 19
San Jose 19
Birmingham 16
London 16
Zurich 16
Frankfurt am Main 14
Paris 14
Philadelphia 14
Stanford 14
Toronto 14
Bengaluru 13
Bremen 13
Clearwater 13
Enfield 13
Henderson 13
Amsterdam 12
Chengdu 12
Muizenberg 12
Padova 12
Phoenix 12
Provo 11
Barcelona 10
Boston 10
Brooklyn 10
Columbus 10
Melbourne 10
Ottawa 10
Redmond 10
Wuhan 10
Fremont 9
Helsinki 9
Central District 8
Dublin 8
Florence 8
Lahore 8
Leuven 8
Madison 8
Riva Del Garda 8
Sydney 8
Valencia 8
Verona 8
Council Bluffs 7
Guangzhou 7
Riva 7
San Francisco 7
Andover 6
Bern 6
Bolzano 6
Budapest 6
Citta Sant'angelo 6
Dearborn 6
Jakarta 6
Kanpur 6
Latisana 6
Montreal 6
Nanjing 6
Taipei 6
Weiden 6
Wolcott 6
Yellow Springs 6
Adelaide 5
Atlanta 5
Bologna 5
Chiyoda-ku 5
Edinburgh 5
Leawood 5
Moscow 5
Totale 3.567
Nome #
Personalized in vitro and in vivo cancer models to guide precision medicine, file e3835193-a4b8-72ef-e053-3705fe0ad821 630
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit, file e3835193-fccf-72ef-e053-3705fe0ad821 374
Inherited determinants of early recurrent somatic mutations in prostate cancer, file e3835194-019f-72ef-e053-3705fe0ad821 357
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models, file e3835198-fec5-72ef-e053-3705fe0ad821 280
EthSEQ: ethnicity annotation from whole exome sequencing data, file e3835193-a46f-72ef-e053-3705fe0ad821 232
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer, file e3835193-07a9-72ef-e053-3705fe0ad821 215
TPES: Tumor Purity Estimation from SNVs, file e3835195-d5cf-72ef-e053-3705fe0ad821 212
Mutation–selection balance and compensatory mechanisms in tumour evolution, file e3835198-d830-72ef-e053-3705fe0ad821 202
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer, file e3835196-534a-72ef-e053-3705fe0ad821 197
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood, file e3835195-d89c-72ef-e053-3705fe0ad821 177
Patient derived organoids to model rare prostate cancer phenotypes, file e3835195-fa19-72ef-e053-3705fe0ad821 172
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer, file e3835193-42fe-72ef-e053-3705fe0ad821 171
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study, file e3835193-b004-72ef-e053-3705fe0ad821 168
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data, file e3835196-5348-72ef-e053-3705fe0ad821 121
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer, file e3835199-d383-72ef-e053-3705fe0ad821 112
ASEQ: Fast allele-specific studies from next-generation sequencing data, file e3835193-4d8e-72ef-e053-3705fe0ad821 109
The long tail of oncogenic drivers in prostate cancer, file e3835198-fec7-72ef-e053-3705fe0ad821 101
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity, file e3835199-0779-72ef-e053-3705fe0ad821 101
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer, file e3835193-4856-72ef-e053-3705fe0ad821 97
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations, file e3835196-3d28-72ef-e053-3705fe0ad821 93
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer, file e3835197-13f8-72ef-e053-3705fe0ad821 88
A highly specific SpCas9 variant is identified by in vivo screening in yeast, file e3835198-7935-72ef-e053-3705fe0ad821 88
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model, file e3835193-4736-72ef-e053-3705fe0ad821 85
Circulating RNAs in prostate cancer patients, file e3835199-b470-72ef-e053-3705fe0ad821 83
Tumor purity quantification by clonal DNA methylation signatures, file e3835198-be09-72ef-e053-3705fe0ad821 81
Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2, file e3835199-0777-72ef-e053-3705fe0ad821 78
Ancestry-specific predisposing germline variants in cancer, file e3835197-1ca7-72ef-e053-3705fe0ad821 75
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer, file e3835199-51be-72ef-e053-3705fe0ad821 74
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth, file e3835197-e1c7-72ef-e053-3705fe0ad821 73
Genomic correlates of clinical outcome in advanced prostate cancer, file e3835195-d2d8-72ef-e053-3705fe0ad821 72
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes, file e3835197-437c-72ef-e053-3705fe0ad821 71
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies, file e3835199-87c0-72ef-e053-3705fe0ad821 66
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers, file e3835198-9020-72ef-e053-3705fe0ad821 61
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer, file e3835198-96c9-72ef-e053-3705fe0ad821 57
Therapy considerations in neuroendocrine prostate cancer: What next?, file e3835199-e64f-72ef-e053-3705fe0ad821 52
Analytical protocol to identify local ancestry-associated molecular features in cancer, file e3835198-df86-72ef-e053-3705fe0ad821 42
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations, file e3835199-9d31-72ef-e053-3705fe0ad821 34
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer, file e3835198-a493-72ef-e053-3705fe0ad821 30
Mutation–selection balance and compensatory mechanisms in tumour evolution, file e3835198-fec9-72ef-e053-3705fe0ad821 26
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer, file e3835199-e64b-72ef-e053-3705fe0ad821 24
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients, file e3835194-f887-72ef-e053-3705fe0ad821 23
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer, file e3835198-8851-72ef-e053-3705fe0ad821 21
Charting differentially methylated regions in cancer with Rocker-meth, file e3835199-bdcc-72ef-e053-3705fe0ad821 18
Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2, file e3835198-dfd4-72ef-e053-3705fe0ad821 16
Clonal evolution of chemotherapy-resistant urothelial carcinoma, file e3835198-956e-72ef-e053-3705fe0ad821 15
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations, file e3835199-5945-72ef-e053-3705fe0ad821 10
Clonal evolution of chemotherapy-resistant urothelial carcinoma, file e3835193-4cf4-72ef-e053-3705fe0ad821 7
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation, file 1266738d-5c17-4ae7-894e-0ee8441bd1d4 6
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer, file e3835193-42f9-72ef-e053-3705fe0ad821 6
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer, file e3835193-a3ca-72ef-e053-3705fe0ad821 6
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer, file e3835196-3d24-72ef-e053-3705fe0ad821 6
A highly specific SpCas9 variant is identified by in vivo screening in yeast, file e3835194-695a-72ef-e053-3705fe0ad821 5
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations, file e3835198-3981-72ef-e053-3705fe0ad821 5
Inherited variant in NFκB‐1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding, file e3835196-e57f-72ef-e053-3705fe0ad821 4
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies, file e3835199-85a6-72ef-e053-3705fe0ad821 4
Plasma AR and abiraterone-resistant prostate cancer, file e3835193-582e-72ef-e053-3705fe0ad821 3
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response, file e3835194-f8d3-72ef-e053-3705fe0ad821 3
ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA, file e3835196-5aec-72ef-e053-3705fe0ad821 3
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer, file e3835197-1f96-72ef-e053-3705fe0ad821 3
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers, file e3835198-3989-72ef-e053-3705fe0ad821 3
Prostate cancer: Intrapatient heterogeneity in prostate cancer, file e3835193-42fb-72ef-e053-3705fe0ad821 2
Role of non-coding sequence variants in cancer, file e3835193-45af-72ef-e053-3705fe0ad821 2
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients, file e3835193-536c-72ef-e053-3705fe0ad821 2
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes., file e3835192-92c7-72ef-e053-3705fe0ad821 1
Voices of biotech, file e3835193-4302-72ef-e053-3705fe0ad821 1
Integrative clinical genomics of advanced prostate cancer, file e3835193-46e3-72ef-e053-3705fe0ad821 1
SPOP mutation leads to genomic instability in prostate cancer, file e3835193-4acc-72ef-e053-3705fe0ad821 1
In-silico identification and functional validation of allele-dependent AR enhancers, file e3835193-4d0f-72ef-e053-3705fe0ad821 1
The Molecular Taxonomy of Primary Prostate Cancer, file e3835193-53a7-72ef-e053-3705fe0ad821 1
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer, file e3835196-3d2a-72ef-e053-3705fe0ad821 1
Totale 5.561
Categoria #
all - tutte 13.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019169 0 0 1 4 5 19 10 5 21 30 36 38
2019/2020581 29 25 23 70 42 31 44 46 79 93 43 56
2020/20211.160 41 142 106 153 62 76 78 69 52 131 143 107
2021/20221.686 334 147 74 101 86 51 49 83 115 120 324 202
2022/20231.680 118 99 249 207 132 123 166 149 123 93 160 61
2023/2024243 75 90 78 0 0 0 0 0 0 0 0 0
Totale 5.561